LON:MRL Marlowe (MRL) Share Price, News & Analysis GBX 321 0.00 (0.00%) As of 11:46 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades About Marlowe Stock (LON:MRL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Marlowe alerts:Sign Up Key Stats Today's Range 319.10▼ 32150-Day Range 307▼ 34252-Week Range 220▼ 620Volume62,368 shsAverage Volume247,636 shsMarket Capitalization£281.55 millionP/E RatioN/ADividend Yield3.35%Price TargetGBX 700Consensus RatingBuy Company OverviewMarlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.Read More… Marlowe Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks60th Percentile Overall ScoreMRL MarketRank™: Marlowe scored higher than 60% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMarlowe has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMarlowe has received no research coverage in the past 90 days.Read more about Marlowe's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Marlowe is -2,292.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Marlowe is -2,292.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMarlowe has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for MRL. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldMarlowe pays a meaningful dividend of 3.35%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMarlowe does not have a long track record of dividend growth.Read more about Marlowe's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for MRL. News and Social Media2.3 / 5News Sentiment0.22 News SentimentMarlowe has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Industrials companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Marlowe this week, compared to 1 article on an average week.Search Interest1 people have searched for MRL on MarketBeat in the last 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Marlowe insiders have not sold or bought any company stock.Percentage Held by Insiders25.30% of the stock of Marlowe is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.54% of the stock of Marlowe is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Marlowe's insider trading history. Receive MRL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Marlowe and its competitors with MarketBeat's FREE daily newsletter. Email Address MRL Stock News HeadlinesCountry music singer-songwriter Kameron Marlowe to headline Adrian College's Spring ConcertJanuary 19 at 5:39 AM | yahoo.comMarlowe enjoys "Sad Songs For The Soul"January 12, 2025 | countrystandardtime.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.January 21, 2025 | Crypto Swap Profits (Ad)Marlowe swings to profit, expects Budget to impact on marginsDecember 5, 2024 | lse.co.ukMarlowe Announces Total Voting Rights UpdateNovember 29, 2024 | markets.businessinsider.comWe review Marlowe Theatre’s 2024 panto, Beauty and the Beast, starring Maisie Smith and Ben RoddyNovember 28, 2024 | msn.comTerri Miller and Andrew Marlowe, Team Behind ‘The Equalizer' and ‘Castle,' Sign With IAG (EXCLUSIVE)October 16, 2024 | msn.comDylan Marlowe sets live tourOctober 14, 2024 | countrystandardtime.comSee More Headlines MRL Stock Analysis - Frequently Asked Questions How have MRL shares performed this year? Marlowe's stock was trading at GBX 324 at the start of the year. Since then, MRL stock has decreased by 0.9% and is now trading at GBX 321. View the best growth stocks for 2025 here. How were Marlowe's earnings last quarter? Marlowe plc (LON:MRL) issued its earnings results on Thursday, December, 5th. The company reported $6.40 EPS for the quarter. Marlowe had a negative net margin of 2.53% and a negative trailing twelve-month return on equity of 3.11%. How do I buy shares of Marlowe? Shares of MRL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Marlowe own? Based on aggregate information from My MarketBeat watchlists, some other companies that Marlowe investors own include Rolls-Royce Holdings plc (RR.L), SIG (SHI), Tullow Oil (TLW), Alibaba Group (BABA), B&M European Value Retail (BME), BP (BP) and BT Group (BT.A). Company Calendar Last Earnings12/05/2024Today1/21/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorIndustrials Industry Security & Protection Services Sub-IndustryN/A Current SymbolLON:MRL CUSIPN/A CIKN/A Webwww.marloweplc.com Phone+44-20-38138498FaxN/AEmployees4,972Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 700 High Stock Price TargetGBX 710 Low Stock Price TargetGBX 690 Potential Upside/Downside+118.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.14) Trailing P/E RatioN/A Forward P/E Ratio25.71 P/E GrowthN/ANet Income£-13,700,000.00 Net Margins-2.53% Pretax MarginN/A Return on Equity-3.11% Return on Assets1.41% Debt Debt-to-Equity Ratio58.99 Current Ratio1.24 Quick Ratio0.80 Sales & Book Value Annual Sales£402.90 million Price / Sales0.70 Cash FlowGBX 15.17 per share Price / Cash Flow21.17 Book ValueGBX 452 per share Price / Book0.71Miscellaneous Outstanding Shares87,710,000Free FloatN/AMarket Cap£281.55 million OptionableNot Optionable Beta0.44 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report This page (LON:MRL) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marlowe plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Marlowe With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.